Evidence map›Paper›PMID 26835221›Full record

ArticleSpringerPlus2016

Alcohol and breast cancer tumor subtypes in a Spanish Cohort.

Manuela Gago-Dominguez, J Esteban Castelao, Francisco Gude, Maite Peña Fernandez, Miguel E Aguado-Barrera, Sara Miranda Ponte, Carmen M Redondo, Manuel Enguix Castelo, Alejandro Novo Dominguez, Víctor Muñoz Garzón and 2 more

Abstract read
In one paragraph

Article in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Manuela Gago-Dominguez *Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.ORCID 0000-0001-6713-4351
J Esteban Castelao *Oncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) Orense-Pontevedra-Vigo. Xerencia de Xestión Integrada de Vigo-SERGAS, Vigo, Spain.
Francisco GudeClinical Epidemiology Unit, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.
Maite Peña FernandezGinecology Department, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.
Miguel E Aguado-BarreraGenomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.
Sara Miranda PonteOncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) Orense-Pontevedra-Vigo. Xerencia de Xestión Integrada de Vigo-SERGAS, Vigo, Spain.
Carmen M RedondoOncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) Orense-Pontevedra-Vigo. Xerencia de Xestión Integrada de Vigo-SERGAS, Vigo, Spain.
Manuel Enguix CasteloRadiotherapy Department, Complejo Hospitalario Universitario de Vigo, SERGAS, Vigo, Spain.
Alejandro Novo DominguezGinecology Department, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.
Víctor Muñoz GarzónRadiotherapy Department, Complejo Hospitalario Universitario de Vigo, SERGAS, Vigo, Spain.
Angel CarracedoGenomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.
María Elena MartínezMoores Cancer Center, University of California San Diego, La Jolla, CA USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although alcohol intake is an established risk factor for overall breast cancer, few studies have looked at the relationship between alcohol use and breast cancer risk by the four major subtypes of breast cancer and very few data exist in the alcohol-breast cancer relationship in Spanish women. A population-based case-control study was conducted in Galicia, Spain. A total of 1766 women diagnosed with invasive breast cancer between 1997 and 2014 and 833 controls participated in the study. Data on demographics, breast cancer risk factors, and clinico-pathological characteristics were collected. We examined the alcohol-breast cancer association according to the major breast cancer subtypes [hormone-receptor-positive, HER2-negative (luminal A); hormone-receptor-positive, HER2-positive (luminal B); hormone-receptor-negative, HER2-negative (TNBC); and hormone-receptor-negative, HER2-positive (HER2 overexpressing)] as well as grade and morphology in Spanish women. With the exception of HER2 overexpressing, the risk of all subtypes of breast cancer significantly increased with increasing alcohol intake. The association was similar for hormonal receptor positive breast cancer, i.e., luminal A and luminal B breast cancer (odds ratio, OR 2.16, 95 % confidence interval, CI 1.55-3.02; and OR 1.98, 95 % CI 1.11-3.53, respectively), and for TNBC (TNBC: OR 1.93, 95 % CI 1.07-3.47). The alcohol-breast cancer association was slightly more pronounced among lobular breast cancer (OR 2.76, 95 % CI 1.62-4.69) than among ductal type breast cancers (OR 2.21, 95 % CI 1.61-3.03). In addition, significant associations were shown for all grades, I, II and III breast cancer (OR 1.98, 95 % CI 1.26-3.10; OR 2.34, 95 % CI 1.66-3.31; and OR 2.16, 95 % CI 1.44-3.25 for Grades I, II and III, respectively). To our knowledge, this is the first study to examine the association of breast cancer subtypes and alcohol intake in Spanish women. Our findings indicate that breast cancer risk increased with increasing alcohol intakes for three out of the four major subtypes of breast cancer. The association was similar for hormonal receptor positive breast cancer, i.e., luminal A and luminal B breast cancer, and for TNBC. The association seemed to be slightly more pronounced for lobular than ductal breast cancers. No differences were detected by grade.

Identifiers

PMID26835221
PMCPMC4715100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.